Revolution or Mere Evolution? Flow Cytometry and Verification of Cleanin...
New Temperate Rocky Worlds Discovery – Tracing the Emergence of Biology
WITec Jubilee Celebrates 25 Years of Innovation
Chromatography Column Packs Support Protein Purification Workflows
Smart Laboratories - The Future of the Lab
Benchtop MALDI-TOF Mass Spectrometer with Dual-polarity Ion Source
Finnish business Medix Biochemica has broadened its portfolio of molecular diagnostic raw materials for the in vitro diagnostics industry, through the acquisition of myPOLS Biotec which will continue with its operations in Konstanz, Germany. Forming a significant part of the newly established Molecular Diagnostics Business Unit within the parent group, all founders of myPOLS Biotec remain involved in the business.
“This acquisition is a great step towards our vision to be the first-choice, independent raw material partner for the IVD industry and it further accelerates Medix Biochemica’s growth in molecular diagnostics reagents business which is a key strategic expansion area for us. The broad portfolio of myPOLS Biotec, including unique and innovative molecular diagnostics reagents, complements Medix Biochemica’s existing molecular diagnostics offering. With myPOLS technology, we enable customers to shorten their assay development time and complexity and perform molecular testing directly from crude samples. We will offer more flexibility in assay development by partnering in custom development projects. We are excited about the opportunity to offer these molecular diagnostics products to our global customer base,” said Steve Ferguson, CEO of Medix Biochemica.
“We are thrilled to join Medix Biochemica Group,” commented Dr. Ramon Kranaster, CEO of myPOLS Biotec. “We are looking forward to contributing to the strong growth of Medix Biochemica and we appreciate its clear focus on quality and R&D. The high scientific competence of the myPOLS team including best-in-class DNA polymerases, supports Medix Biochemica’s long term vision and focus on IVD customers’ needs.”
“It is important to detect as many temperate terrestrial worlds as possible to study the diversity of exoplanet climates and eventually to be in a position...
Steve Smith has been appointed as the new Managing Director at Hi-Line Industries, a UK-based leader in the design, manufacture and installation of energy-ef...
Leading Australian biopharmaceutical CDMO, AcuraBio (formerly Luina Bio), has been acquired by biotech investor Dr Glenn Haifer and Ampersand Capital Partner...
ExcellGene SA has announced its role in the recently approved consortium funding through the Coalition for Epidemic Preparedness Innovations (CEPI), a global...
In This Edition Chromatography Articles - Eco-Friendly RP-HPLC - Replacing Acetonitrile with mIsopropanol in analytical and purifi cation utilising Core-Shell Chromatography Mass Spectrome...
Sep 14 2022 Bitec Hall, Bangkok, Thailand
Analytica Anacon India & IndiaLabExpo
International Labmate Limited Oak Court Business Centre Sandridge Park, Porters Wood St Albans Hertfordshire AL3 6PH United Kingdom
T +44 (0)1727 858 840 F +44 (0)1727 840 310 E info@labmate-online.com
Copyright © 2022 Labmate Online. All rights reserved.